Literature DB >> 10783148

Elevated serum free fatty acid concentrations inhibit T lymphocyte signaling.

T M Stulnig1, M Berger, M Roden, H Stingl, D Raederstorff, W Waldhäusl.   

Abstract

Unbound cis-unsaturated free (i.e., nonesterified) fatty acids (FFA) inhibit T lymphocyte activation in vitro and therefore may exert immunosuppressive effects. However, in blood serum the major proportion of FFA is tightly bound to albumin, whereas unbound FFA are hardly detectable. Since serum FFA elevation occurs under pathological conditions like insulin resistance or cancer, which are often associated with a disturbed immune response, we addressed the question of whether increased serum FFA concentrations could affect T lymphocyte activation under in vivo conditions. Our studies revealed that 1) addition of pure long-chain cis-unsaturated FFA in the absence of albumin inhibited calcium response in cultured Jurkat T cells. 2) In healthy volunteers, serum FFA elevation by a lipid/heparin infusion, including predominantly unsaturated fatty acids, decreased calcium response of cultured T cells in contrast to studies without heparin. 3) Most notably, stepwise increasing serum FFA by lipid/heparin infusion also inhibited calcium response of simultaneously isolated autologous peripheral blood T lymphocytes as well as their CD4(+) and CD8(+) subsets. In conclusion, our data emphasize that serum FFA elevation is able to exert immunosuppressive effects in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783148     DOI: 10.1096/fasebj.14.7.939

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

Review 1.  Bio-ecological control of perioperative and ITU morbidity.

Authors:  Stig Bengmark
Journal:  Langenbecks Arch Surg       Date:  2003-11-07       Impact factor: 3.445

2.  Unbound free fatty acid profiles in human plasma and the unexpected absence of unbound palmitoleate.

Authors:  Andrew H Huber; Alan M Kleinfeld
Journal:  J Lipid Res       Date:  2017-01-12       Impact factor: 5.922

3.  Changes in leukocyte populations of cows with milk fever or displaced abomasum after calving.

Authors:  Hiromichi Ohtsuka; Shigeo Fukuda; Katsunori Kudo; Michiko Tomioka; Masateru Koiwa; Kayoko Kimura
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

4.  Plasma unbound free fatty acid profiles in premature infants before and after intralipid infusion.

Authors:  Thomas Hegyi; Barry Weinberger; Naureen Memon; Mary Carayannopoulos; Andrew H Huber; Alan M Kleinfeld
Journal:  J Matern Fetal Neonatal Med       Date:  2018-12-17

5.  The negative effect of lipid challenge on autophagy inhibits T cell responses.

Authors:  Ignacio Guerrero-Ros; Cristina C Clement; Cara A Reynolds; Bindi Patel; Laura Santambrogio; Ana M Cuervo; Fernando Macian
Journal:  Autophagy       Date:  2019-04-25       Impact factor: 16.016

6.  Effects of a beta3-adrenergic agonist on the immune response in diet-induced (cafeteria) obese animals.

Authors:  O Lamas; J A Martínez; A Marti
Journal:  J Physiol Biochem       Date:  2003-09       Impact factor: 4.158

7.  Effects of soybean lipid infusion on triglyceride and unbound free fatty acid levels in preterm infants.

Authors:  Thomas Hegyi; Alan Kleinfeld; Andrew Huber; Barry Weinberger; Naureen Memon; Weichung Joe Shih; Mary Carayannopoulos; William Oh
Journal:  J Matern Fetal Neonatal Med       Date:  2018-04-18

8.  In the eye of the storm: T cell behavior in the inflammatory microenvironment.

Authors:  Robert Haas; Federica Marelli-Berg; Claudio Mauro
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

9.  Cytotoxicity of unsaturated fatty acids in fresh human tumor explants: concentration thresholds and implications for clinical efficacy.

Authors:  David E Scheim
Journal:  Lipids Health Dis       Date:  2009-12-15       Impact factor: 3.876

Review 10.  Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer.

Authors:  Ivan J Cohen; Ronald Blasberg
Journal:  Breast Cancer (Auckl)       Date:  2017-09-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.